Thyroid Carcinoma, Anaplastic
1 competing product in clinical development for Thyroid Carcinoma, Anaplastic.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib 24 mg | Eisai | Phase 2 | Terminated | 27 |
1 competing product in clinical development for Thyroid Carcinoma, Anaplastic.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib 24 mg | Eisai | Phase 2 | Terminated | 27 |